↗11 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$2.2MSold on the market
1Companies
Oct 7, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 202616:08 | Oct 5, 2026 | PCVXVaxcyte, Inc. | EVP, Chief Scientific Ofc, COO | S · Sell10b5-1 | $86.74 | −18,000 | 145,435 | -11% | −$1.6M | ||
| Oct 7, 202616:08 | Oct 5, 2026 | PCVXVaxcyte, Inc. | EVP, Chief Scientific Ofc, COO | M · Exercise10b5-1 | $5.35 | +18,000 | 163,435 | +12% | $96K | ||
| Oct 2, 202616:05 | Oct 1, 2026 | PCVXVaxcyte, Inc. | EVP, Chief Scientific Ofc, COO | S · Sell10b5-1 | $56.67 | −2,250 | 145,435 | -2% | −$128K | ||
| Oct 2, 202616:05 | Oct 1, 2026 | PCVXVaxcyte, Inc. | EVP, Chief Scientific Ofc, COO | M · Exercise10b5-1 | $5.35 | +2,250 | 147,685 | +2% | $12K | ||
| Sep 9, 202617:46 | Sep 9, 2026from Sep 4, 2026 | PCVXVaxcyte, Inc. | EVP, Chief Scientific Ofc, COO | S · Sell10b5-1 | $60.35 | −2,715 | 145,435 | -2% | −$164K | ||
| Sep 9, 202617:46 | Sep 8, 2026 | PCVXVaxcyte, Inc. | EVP, Chief Scientific Ofc, COO | F · Tax10b5-1 | $60.36 | −5,459 | 146,769 | -4% | $330K | ||
| Sep 2, 202619:58 | Sep 1, 2026 | PCVXVaxcyte, Inc. | CHIEF OPERATING OFFICER | S · Sell10b5-1 | $61.07 | −3,477 | 155,041 | -2% | −$212K | ||
| Sep 2, 202619:58 | Sep 1, 2026 | PCVXVaxcyte, Inc. | CHIEF OPERATING OFFICER | M · Exercise10b5-1 | $5.35 | +2,250 | 158,518 | +1% | $12K | ||
| Sep 2, 202619:58 | Sep 2, 2026from Aug 31, 2026 | PCVXVaxcyte, Inc. | CHIEF OPERATING OFFICER | F · Tax10b5-1 | $61.18 | −2,705 | 153,609 | -2% | $166K | ||
| Aug 5, 202616:59 | Aug 3, 2026 | PCVXVaxcyte, Inc. | CHIEF OPERATING OFFICER | S · Sell10b5-1 | $53.86 | −2,250 | 157,541 | -1% | −$121K | ||
| Aug 5, 202616:59 | Aug 3, 2026 | PCVXVaxcyte, Inc. | CHIEF OPERATING OFFICER | M · Exercise10b5-1 | $5.35 | +2,250 | 159,791 | +1% | $12K |